Casañas, Rocío
Castellvi, Pere
Gil, Juan-José
Torres-Torres, María
Barón, Jesica
Teixidó, Mercè
Sampietro, Hernán María
Díez, Marta
Fernández, Raúl
Sorli, Raquel
Siñol, Patricia
Jurado, Francisca
Carreras-Salvador, Regina
Vazquez, Davinia
Gonzalez, Sandra
Martín, Maria Isabel Fernandez-San
Raya-Tena, Antonia
Alvarez, Rosa
Amado-Rodriguez, Isaac
López, Luis Miguel Martín-
Alonso, Jordi
Lalucat-Jo, Lluís
Funding for this research was provided by:
Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain). (PI15/01613, PI15/01613, PI15/01613, PI15/01613, PI15/01613, PI15/01613, PI15/01613)
Department of Health, Government of Catalonia (SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202, SLT002/16/00202)
Article History
Received: 29 November 2021
Accepted: 7 November 2022
First Online: 24 December 2022
Declarations
:
: The Independent Ethics Committee at the Fundació Unio Catalana Hospitals in Barcelona (Spain) approved the trial study protocol. The trial has also been registered on the Clinical.Trial.gov register (NCT03215654; registration data 12/07/2017).Written informed consent of the parents or legal guardians of all students participating in the study was obtained.The methods were carried out in accordance with the relevant guidelines and regulations. The principles established in the Declaration of Helsinki, in the Council of Europe agreement on human rights and biomedicine, as well as the requirements established in the Spanish legislation were respected. It was complied with the protection of personal data and confidentiality (European Data Protection Regulation, and in accordance with the Organic Law 3/2018 Protection of Personal Data and guarantee of digital rights).
: Not applicable.
: The authors declare that they have no competing interests.